Cargando…
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay
Background: Monitoring antibody response following SARS-CoV-2 vaccination is strategic, and neutralizing antibodies represent the gold standard. The neutralizing response to Beta and Omicron VOCs was evaluated versus the gold standard by a new commercial automated assay. Methods: Serum samples from...
Autores principales: | Fogolari, Marta, Leoni, Bruno Daniele, De Cesaris, Marina, Italiano, Rita, Davini, Flavio, Miccoli, Ginevra Azzurra, Donati, Daniele, Clerico, Luigi, Stanziale, Andrea, Savini, Giovanni, Petrosillo, Nicola, Ciccozzi, Massimo, Sommella, Lorenzo, Riva, Elisabetta, Fazii, Paolo, Angeletti, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000738/ https://www.ncbi.nlm.nih.gov/pubmed/36900033 http://dx.doi.org/10.3390/diagnostics13050889 |
Ejemplares similares
-
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
por: Meyer, Benjamin, et al.
Publicado: (2020) -
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
por: Winichakoon, Poramed, et al.
Publicado: (2023) -
Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination()
por: Pezzati, Laura, et al.
Publicado: (2023) -
Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy
por: Angeletti, Silvia, et al.
Publicado: (2022) -
Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA
por: Tuells, José, et al.
Publicado: (2022)